Compare WOLF & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WOLF | HAE |
|---|---|---|
| Founded | 1987 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.8B |
| IPO Year | 2025 | 1996 |
| Metric | WOLF | HAE |
|---|---|---|
| Price | $56.58 | $73.70 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $14.33 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 7.8M | 1.0M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.05 |
| Revenue | ★ $1,385,982,000.00 | $910,373,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.43 | $5.23 |
| P/E Ratio | ★ N/A | $36.16 |
| Revenue Growth | ★ 19.00 | N/A |
| 52 Week Low | $0.39 | $47.32 |
| 52 Week High | $80.82 | $87.32 |
| Indicator | WOLF | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 54.83 | 61.31 |
| Support Level | $51.72 | $48.98 |
| Resistance Level | $71.87 | $86.72 |
| Average True Range (ATR) | 8.01 | 3.24 |
| MACD | -1.46 | -0.15 |
| Stochastic Oscillator | 57.82 | 54.54 |
Wolfspeed Inc develops and manufactures semiconductor technologies based on silicon carbide (SiC) for power electronics applications. Its product portfolio includes SiC MOSFETs, Schottky diodes, and power modules used in power electronics applications. The company also provides reference designs, evaluation kits, and gate driver boards to support the development and integration of its SiC products across industries such as electric vehicles, renewable energy, and industrial systems.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.